Home » MEDTRONIC SEEN CAPITALIZING ON GUIDANT'S WOES
MEDTRONIC SEEN CAPITALIZING ON GUIDANT'S WOES
Glenn Reicin of Morgan Stanley maintained an "overweight" rating on
Medtronic after the maker of medical devices raised earnings guidance. Medtronic
lifted earnings-per-share guidance for the fiscal years 2006 to 2008 by 8 cents,
citing a more favorable tax rate.
Forbes
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May